Key facts
- It has raised $190K; the latest was Accelerator/Incubator in Jan 2026.
- Notable investors include MassChallenge, Venture Kick, Ecole Polytechnique Federale de Lausanne, Kickfund, Biopole — 7 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for Molesense
- ·The full record, as it builds
Funding rounds
No funding rounds for Molesense are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Molesense
Developer of molecular wearable medical devices designed to track vital signs to continuously and non-invasively monitor biochemical markers. The company offers personalized molecular data with biology-aware machine intelligence, enabling patients with proactive healthcare for high-risk pregnancies.
- Sector
- Healthcare
- HQ
- Epalinges, Switzerland
- Founded
- 2023
- Employees
- 8
- Website
- molesense.ch/
- Ownership
- Privately Held (backing)
Molesense doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Molesense shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Molesense in its N-PORT filings yet. We sweep new filings monthly.